Avid Bioservices CDMO reported its Q2 earnings results on Tuesday, December 7, 2021 at 04:05 PM.
Here's what investors need to know about the announcement.
Avid Bioservices beat estimated earnings by 200%, reporting an EPS of $0.06 versus an estimate of $0.02, which surprised analysts.
Revenue was up $5,045,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.06, which was followed by a 12.05% drop in the share price the next day.
Here's a look at Avid Bioservices's past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.